Ascorbic acid and reducing agents regulate the fates and functions of S-nitrosothiols.
Although S-nitrosoglutathione (GS-NO) and other S-nitrosothiols (RS-NO) exhibit activity attributable to nitric oxide (NO), the dynamic aspects of their metabolism remain to be elucidated. To determine the fates and functions of RS-NO, the stability of GS-NO was analyzed in plasma, and various fractions of liver and kidney. GS-NO was fairly stable under physiological conditions in plasma and buffer solutions. However, GS-NO was rapidly decomposed in the presence of either homogenates of rat liver and kidney or their supernatant fractions. The ability of the supernatants to decompose GS-NO remained unchanged after the removal of proteins and large molecular weight compounds. Physiological levels of reducing agents, such as reduced glutathione (GSH), ascorbic acid (AsA), and cysteine, also enhanced the decomposition of RS-NO; the order of their potency was AsA > cysteine >GSH. Considering their intra-cellular concentrations and potency, AsA might principally be responsible for the enhanced decomposition of GS-NO. NO, GS-NO, and related RS-NO inhibited the respiration of Ehrlich ascites tumor cells. The inhibitory effect of GS-NO was enhanced by the reducing agents (cysteine>AsA>GSH). Intravenously administered GS-NO exhibited a depressor action through some ascorbic acid enhancable mechanism. Thus, the metabolism and biological function of GS-NO and related RS-NO might be affected by AsA and other reducing agents.
Kashiba-Iwatsuki
M
M
Department of Biochemistry, Osaka City University Medical School, Osaka.
Kitoh
K
K
Kasahara
E
E
Yu
H
H
Nisikawa
M
M
Matsuo
M
M
Inoue
M
M
D000818:Animals; D001205:Ascorbic Acid / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D004355:Drug Stability; D005978:Glutathione / Q000031:analogs & derivatives / Q000097:blood / Q000378:metabolism; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D009603:Nitroso Compounds / Q000097:blood / Q000378:metabolism*; D010101:Oxygen Consumption / Q000187:drug effects; D051381:Rats; D019163:Reducing Agents / Q000494:pharmacology*; D026422:S-Nitrosoglutathione; D013438:Sulfhydryl Compounds / Q000378:metabolism / Q000502:physiology*
D009603:Nitroso Compounds; D019163:Reducing Agents; D013438:Sulfhydryl Compounds; D026422:S-Nitrosoglutathione; D005978:Glutathione; D001205:Ascorbic Acid